Specialty Injectable Generics Market, By Product Type, By Application, By Distribution Channel, By Geography
상품코드:1935245
리서치사:Coherent Market Insights
발행일:2026년 01월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
특수 주사용 제네릭 의약품 시장은 2026년에 217억 8,000만 달러로 추정되며, 2033년까지 366억 2,000만 달러에 달할 것으로 예측됩니다. 2026년부터 2033년까지 CAGR 7.8%로 성장할 것으로 전망됩니다.
보고서 내용
보고서 상세
기준 연도:
2025년
2026년 시장 규모:
217억 8,000만 달러
과거 데이터 대상 기간:
2020-2024년
예측 기간:
2026-2033년
예측 기간 2026-2033년 CAGR:
7.80%
2033년의 예측 가치:
366억 2,000만 달러
특수 주사제는 주사, 흡입 또는 점적투여가 필요한 고가의 약물요법입니다. 이 약은 HIV, 류마티스 관절염, 혈우병, 암, 심혈관질환, 감염성 질환, 자가면역 질환, 기타 질환 등 만성 또는 생명을 위협하는 질환의 치료에 사용됩니다.
시장 역학
암, 심혈관질환 등 만성질환의 유병률 증가는 특수주사제 제네릭 시장 성장을 견인하는 주요 요인입니다. 미국 국립암연구소(2013)에 따르면, 암은 발생 원인 세포의 종류에 따라 100가지 이상의 종류로 분류됩니다. 미국암협회(2017)의 보고에 따르면, 암은 미국 내 사망원인 2위이며, 전체 사망자 중 약 4분의 1이 암으로 인한 사망자라고 합니다.
또한, 가까운 장래에 다수의 의약품 및 바이오테크놀러지 제품의 특허가 만료될 예정으로, 특히 고부가가치 시장인 미국 및 유럽 시장에서 시장 성장을 촉진하고 있습니다.
그러나 엄격한 규제 지침, 낮은 수익률, 의약품 부족은 세계 특수 주사제 제네릭 의약품 시장의 성장을 저해할 것으로 예상됩니다. 업계가 직면한 부족은 주로 제조 문제 증가, 공급 지연, 원료의약품(API) 부족으로 인한 것입니다.
본 조사의 주요 특징
이 보고서는 2017년을 기준 연도로 하여 예측 기간(2018-2026년)의 시장 규모와 예측 기간(2018-2026년)의 연평균 성장률(CAGR)을 제시하는 특수 주사제 제네릭 의약품 시장에 대한 상세한 분석 정보를 제공합니다.
또한, 각 부문의 잠재적 수익기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
시장 촉진요인, 저해요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보도 제공합니다.
이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 입지, 유통 전략, 주요 개발, 전략, 미래 계획 등 다양한 매개 변수를 기반으로 세계 특수 주사제 제네릭 의약품 시장의 주요 업체를 프로파일링합니다.
이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 도와줄 것입니다.
이 세계 특수 주사제 제네릭 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 특수 주사제 제네릭 의약품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 보다 쉽게 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 특수 주사용 제네릭 의약품 시장 : 제품 유형별, 2026-2033년
제5장 세계의 특수 주사용 제네릭 의약품 시장 : 용도별, 2026-2033년
제6장 세계의 특수 주사용 제네릭 의약품 시장 : 유통 경로별, 2026-2033년
제7장 세계의 특수 주사용 제네릭 의약품 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 애널리스트의 추천사항
제10장 섹션
KSM
영문 목차
영문목차
Specialty Injectable Generics Market is estimated to be valued at USD 21.78 Bn in 2026 and is expected to reach USD 36.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.
Report Coverage
Report Details
Base Year:
2025
Market Size in 2026:
USD 21.78 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2026 To 2033
Forecast Period 2026 to 2033 CAGR:
7.80%
2033 Value Projection:
USD 36.62 Bn
Specialty injectable is a high cost drug therapy that requires administration by injection, inhalation or infusion. This medication is indicated in treatment of chronic or life threatening diseases such as HIV, rheumatoid arthritis, hemophilia, cancer, cardiovascular diseases, infectious diseases, auto immune disorders, and other diseases.
Market Dynamics
Increasing prevalence of chronic diseases such as cancer and cardiovascular diseases is a major factor driving the specialty injectable generics market growth. According to The National Cancer Institute, 2013, there are over 100 different types of cancers that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.
Moreover, expiration of the patents of majority of pharmaceutical and biotech products in the near future, especially in high value U.S. and Europe market is boosting the market growth.
However, stringent regulatory guidelines and low profit margins and drug shortage is expected to hamper growth of the global specialty injectable generics market. The shortages faced in the industry are primarily due to increased manufacturing issues, delay in supply, and shortage of Active Pharmaceutical Ingredients (API).
Key features of the study
This report provides in-depth analysis of the specialty injectable generics market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global specialty injectable generics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Baxter International Inc., Mylan N.V., Fresenius SE & Co. KGaA, Endo International Plc., Hikma Pharmaceuticals PLC, Lupin Ltd., Sagent Pharmaceuticals, Inc., Cipla Limited , Sun Pharmaceutical Industries Limited, and Dr. Reddy's Laboratories
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global specialty injectable generics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the specialty injectable generics market
Market Segmentation
By Product Type
Drugs
Biologics
By Application
Oncology
Cardiovascular Diseases
Central Nervous System Diseases
Infectious Diseases
Auto-immune Disorders
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Regional Insights
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Novartis AG
Baxter International Inc.
Mylan N.V.
Fresenius SE & Co. KGaA
Endo International Plc.
Hikma Pharmaceuticals PLC
Lupin Ltd.
Sagent Pharmaceuticals, Inc.
Cipla Limited
Sun Pharmaceutical Industries Limited
Reddy's Laboratories
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
PEST Analysis
PORTER's Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend
4. Global Specialty Injectable Generics Market, By Product Type, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Drugs
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Biologics
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Specialty Injectable Generics Market, By Application, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Oncology
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Cardiovascular Disease
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Central Nervous System Disease
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Infectious Disease
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Auto-immune Disorders
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Specialty Injectable Generics Market, By Distribution Channel, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Hospital Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Retail Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
Online Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
7. Global Specialty Injectable Generics Market, By Region, 2026-2033, (USD Bn)
Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
U.S.
Canada
Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
